Daily Briefing

Around the nation: Massachusetts data breach affects over 134K people


Massachusetts health officials on Tuesday announced there was a "global security incident" at UMass Chan Medical School that affected the personal information of more than 134,000 people, in today's bite-sized hospital and health industry news from Maryland, Massachusetts, and New Jersey.

 

  • Maryland: CMS last week announced the fee for out-of-network health plans and providers to resolve payment disputes under the No Surprises Act will return at $50 per party until HHS, the Department of Labor, and the Department of Treasury set a new fee amount. Earlier this month, a federal judge vacated CMS' proposal to increase the fee by seven-fold and increase restrictions on batching related claims within a single dispute. (AHA News, 8/11; AHA News, 8/7)
  • Massachusetts: Massachusetts health officials on Tuesday announced there was a "global security incident" at UMass Chan Medical School that affected the personal information of more than 134,000 people. According to the state's Executive Office of Health and Human Services, the breach "was part of a worldwide data security incident involving a file-transfer software program called MOVEit, which has impacted state and federal government agencies, financial services firms, pension funds, and many other types of companies and not-for-profit organizations." Officials said impacted individuals have been sent notice by mail and will be contacted by phone, text, and e-mail when possible. (Papadopoulos, Boston 25 News, 8/16)
  • New Jersey: Novo Nordisk on Thursday said it plans to take a cautious approach rolling out its obesity drug Wegovy in new markets as demand increases. In an analysts' call Thursday, Novo Nordisk CEO Lars Fruergaard Jørgensen said the best way to make sure all patients that have started Wegovy can reach their highest dosage and achieve results "is of course not to start more patients than we can secure continuity of care, and then furthermore not to launch in more [markets] than we can support." The drugmaker has purchased a second facility from contractor Catalent to help ramp up inventory production, Jørgensen said, adding the company's "supply is going to plan in terms of getting new lines on track." (Collis, PoliticoPRO [subscription required], 8/10)

SPONSORED BY

INTENDED AUDIENCE

AFTER YOU READ THIS

AUTHORS

TOPICS

Don't miss out on the latest Advisory Board insights

Create your free account to access 1 resource, including the latest research and webinars.

Want access without creating an account?

   

You have 1 free members-only resource remaining this month.

1 free members-only resources remaining

1 free members-only resources remaining

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
AB
Thank you! Your updates have been made successfully.
Oh no! There was a problem with your request.
Error in form submission. Please try again.